tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market

Crescent Biopharma (CBIO) Income Statement

Compare
1,022 Followers

Crescent Biopharma Income Statement

Last quarter (Q4 2025), Crescent Biopharma's total revenue was $10.84M, an increase of Infinity% from the same quarter last year. In Q4, Crescent Biopharma's net income was $-92.40M. See Crescent Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 10.84M$ 0.00$ 10.00K$ 75.00K$ 1.16M
Gross Profit
$ 10.76M$ -35.17K$ 10.00K$ 75.00K$ 1.16M
Operating Expenses
$ 163.39M$ 68.76M$ 39.29M$ 47.48M$ 64.61M
Depreciation and Amortization
$ 84.00K$ 68.76M$ 153.30K$ 207.15K$ 264.60K
EBITDA
$ -149.67M$ 0.00$ -39.12M$ -47.20M$ -63.18M
Operating Income
$ -152.63M$ -68.76M$ -39.28M$ -47.40M$ -63.45M
Other Income/Expenses
$ 690.00K$ -2.70M$ 2.38M$ 714.96K$ 19.77K
Pretax Income
$ -151.94M$ -71.47M$ -36.90M$ -46.69M$ -63.43M
Net Income
$ -149.94M$ -71.47M$ -36.90M$ -46.69M$ -63.43M
Per Share Metrics
Basic EPS
$ 0.06$ -0.59$ -0.58$ -0.89$ -1.23
Diluted EPS
$ 0.02$ -0.59$ -0.58$ -0.89$ -1.23
Weighted Average Shares Outstanding
104.14M 64.48M 63.34M 52.53M 51.45M
Weighted Average Shares Outstanding (Diluted)
104.14M 64.48M 63.34M 52.53M 51.45M
Currency in USD

Crescent Biopharma Earnings and Revenue History